DBV Technologies
DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration.
Wikipage disambiguates
Link from a Wikipage to another Wikipage
primaryTopic
DBV Technologies
DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration.
has abstract
DBV Technologies SA is a publi ...... Food and Drug Administration.
@en
DBV Technologies est une entre ...... st cotée à la bourse de Paris.
@fr
founding year
industry
Link from a Wikipage to an external page
Wikipage page ID
38,460,994
page length (characters) of wiki page
Wikipage revision ID
1,002,896,868
Link from a Wikipage to another Wikipage
foundation
Bagneux, France
@en
founder
@en
Bertrand Dupont
@en
Christophe Dupont
@en
industry
key people
@en
Daniel Tasse
@en
Kevin Trapp
@en
Ramzi Benamar
@en
location city
location country
logo
@en
logo size
name
DBV Technologies SA
@en
products
Allergy treatments, Allergy diagnosis
@en
trade name
DBV Technologies
@en
traded as
Euronext:DBV
@en
wikiPageUsesTemplate
subject
comment
DBV Technologies SA is a publi ...... Food and Drug Administration.
@en
DBV Technologies est une entre ...... st cotée à la bourse de Paris.
@fr
label
DBV Technologies
@en
DBV Technologies
@fr
closeMatch
wasDerivedFrom
homepage
isPrimaryTopicOf
name
DBV Technologies SA
@en